Observational studyJournal of epidemiology and global health2025
TB Incidence Trends in the Kingdom of Saudi Arabia within the GCC, EMR, and MENA Regions, to Achieve the WHO and UN's SDG End TB Strategy Targets.
Observational study in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The prevalence of latent tuberculosis infection among healthcare workers in Saudi Arabia: a systematic review and meta-analysis.IJID regions · 2026Article
- Prevalence of tuberculosis-related chest radiographic abnormalities among individuals with latent tuberculosis infection in Gulf Cooperation Council countries: A systematic review and meta-analysis.New microbes and new infections · 2026Review
- Tuberculosis surveillance indicators and chest radiograph phenotype clustering in southwestern Saudi Arabia, 2010-2020.Tropical medicine and health · 2026Article
- Commentary: The effects of postponing BCG vaccination on the risk of BCG-related complications among patients with severe combined immunodeficiency disease in Saudi Arabia.Frontiers in immunology · 2026Article
- Response: Commentary: The effects of postponing BCG vaccination on the risk of BCG-related complications among patients with severe combined immunodeficiency disease in Saudi Arabia.Frontiers in immunology · 2026Article
- Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the tuberculosis (TB) incidence trends, between 2000 and 2023, in the Kingdom of Saudi Arabia (KSA), in comparison to that in different geopolitical regions where the KSA is commonly included within, and to determine whether the KSA achieved the World Health Organization (WHO) and the United Nations (UN) Sustainable Development Goals (SDGs) End TB Strategy milestones and targets, including the reduction of the total TB incidence by 20% in 2020 compared to that of 2015.
methodsThis is a retrospective observational study on the TB incidence per 100,000 population arising in a given year as reported annually to the WHO. The data was extracted from the WHO indicator dataset. TB incidence data from the KSA, the World, the Gulf Cooperation Council (GCC), the Eastern Mediterranean region (EMR), and the Middle East and North Africa (MENA) region were included. Descriptive analysis and chi-square test were used to compare incidence differences and their statistical significance.
resultsThe TB incidence per 100,000 population in KSA in 2023 was 8.4 (95% uncertainty interval [UI]: 7.6–9.3), in 2020 it was 8.7 (95% UI:7.7–9.6), in 2015 it was 12 (95% UI: 11–13), in 2000 it was 23 (95% UI: 21–26). Compared to 2023, the reduction from 2000, 2015, and 2020 were − 14.6 (63.5% p < 0.01), − 3.6 (30%), and − 0.3 (3.4%), respectively. Compared to 2015, the reduction in 2020 was − 3.3 (27.5%). For 2023, compared to the GCC countries, the KSA had the second lowest incidence after the United Arab Emirates (UAE), which was − 7.6 less than KSA (p < 0.01). The incidence in Qatar was the highest, which was + 26.6 higher than KSA (p < 0.01). Compared to the MENA and EMR, only Jordan had a lower incidence, which was − 5.0 less than KSA. Pakistan had the highest incidence rate and the highest difference from the KSA by + 268.6 (p < 0.01).
conclusionTB incidence trends are decreasing in KSA, and it is among the top three regional countries with the lowest incidence rates. Compared with 2015, KSA exceeded the 20% milestone by achieving a 27.5% reduction in 2020. The KSA is heading towards achieving the WHO and UN’s SDG End TB Strategy targets of a 50% reduction by 2025, 80% by 2030, and 90% by 2035, to fulfill the vision of a world free of TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.